---
type: "Lives"
title: "BioMarin Pharmaceutical Inc. (BMRN.US) Q4 2025 Earnings Conference Call"
locale: "en"
url: "https://longbridge.com/en/lives/342028.md"
parent: "https://longbridge.com/en/lives.md"
status: "✅ Ended"
datetime: "2026-02-24T04:14:00.000Z"
locales:
  - [en](https://longbridge.com/en/lives/342028.md)
  - [zh-CN](https://longbridge.com/zh-CN/lives/342028.md)
  - [zh-HK](https://longbridge.com/zh-HK/lives/342028.md)
---

# BioMarin Pharmaceutical Inc. (BMRN.US) Q4 2025 Earnings Conference Call

> ✅ Ended | Earnings Call

- **Datetime**: 2026-02-24T04:14:00.000Z
- **Duration**: 1h 3m
- **Host**: Live Assistant
- **Replay**: ✅ Available
- **Replay URL**: [Audio](https://tts.pbkrs.com/live/roadshow/file/video/roadshow/2026/02/audio/4873639.mp3?remote_token=BUvYpycygAZhzNAt)

拜玛林制药 (BMRN.US) 2025 年第四季度业绩电话会

## Related Stocks

- [BMRN.US](https://longbridge.com/en/quote/BMRN.US.md)

## Related Filings

### BioMarin Pharma | (10-K) Basic annual filing — 2026-02-26T12:30:49-05:00

- [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-20251231.htm)
- [EX-10.18](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-2025xexx1018.htm)
- [EX-21.1](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-2025xexx211.htm)
- [EX-23.1](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-2025xexx231.htm)
- [EX-31.1](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-exx311xq42025.htm)
- [EX-31.2](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-exx312xq42025.htm)
- [EX-32](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-exx32xamendedandresta.htm)
- [EX-32.1](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/bmrn-exx321xq42025.htm)

### BioMarin Pharma | (8-K) Current Report — 2026-02-23T16:08:42-05:00

- [8-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000002/bmrn-20260223.htm)
- [EX-99.1](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000002/earningsrelease-23feb26ex9.htm)